• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制性微小RNA-137负向调节Musashi-1及结直肠癌进展。

Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression.

作者信息

Smith Amber R, Marquez Rebecca T, Tsao Wei-Chung, Pathak Surajit, Roy Alexandria, Ping Jie, Wilkerson Bailey, Lan Lan, Meng Wenjian, Neufeld Kristi L, Sun Xiao-Feng, Xu Liang

机构信息

Department of Molecular Biosciences, University of Kansas, Lawrence, KS, USA.

Department of Oncology, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.

出版信息

Oncotarget. 2015 May 20;6(14):12558-73. doi: 10.18632/oncotarget.3726.

DOI:10.18632/oncotarget.3726
PMID:25940441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4494958/
Abstract

Stem cell marker, Musashi-1 (MSI1) is over-expressed in many cancer types; however the molecular mechanisms involved in MSI1 over-expression are not well understood. We investigated the microRNA (miRNA) regulation of MSI1 and the implications this regulation plays in colorectal cancer. MicroRNA miR-137 was identified as a MSI1-targeting microRNA by immunoblotting and luciferase reporter assays. MSI1 protein was found to be highly expressed in 79% of primary rectal tumors (n=146), while miR-137 expression was decreased in 84% of the rectal tumor tissues (n=68) compared to paired normal mucosal samples. In addition to reduced MSI1 protein, exogenous expression of miR-137 inhibited cell growth, colony formation, and tumorsphere growth of colon cancer cells. Finally, in vivo studies demonstrated that induction of miR-137 can decrease growth of human colon cancer xenografts. Our results demonstrate that miR-137 acts as a tumor-suppressive miRNA in colorectal cancers and negatively regulates oncogenic MSI1.

摘要

干细胞标志物Musashi-1(MSI1)在多种癌症类型中过度表达;然而,MSI1过度表达所涉及的分子机制尚未完全明确。我们研究了MSI1的微小RNA(miRNA)调控及其在结直肠癌中的作用。通过免疫印迹和荧光素酶报告基因检测,发现微小RNA miR-137是靶向MSI1的微小RNA。在79%的原发性直肠肿瘤(n=146)中发现MSI1蛋白高表达,而与配对的正常黏膜样本相比,84%的直肠肿瘤组织(n=68)中miR-137表达降低。除了降低MSI1蛋白水平外,miR-137的外源性表达还抑制了结肠癌细胞的生长、集落形成和肿瘤球生长。最后,体内研究表明,miR-137的诱导可降低人结肠癌异种移植瘤的生长。我们的结果表明,miR-137在结直肠癌中作为一种肿瘤抑制性miRNA发挥作用,并对致癌性MSI1起负调控作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/d19b9b6b127b/oncotarget-06-12558-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/795be210d0aa/oncotarget-06-12558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/54ff2a21dbdf/oncotarget-06-12558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/ef3ebd8380bc/oncotarget-06-12558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/6ff108ab664a/oncotarget-06-12558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/ac06ea8007f8/oncotarget-06-12558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/e228b9b5f826/oncotarget-06-12558-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/d19b9b6b127b/oncotarget-06-12558-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/795be210d0aa/oncotarget-06-12558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/54ff2a21dbdf/oncotarget-06-12558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/ef3ebd8380bc/oncotarget-06-12558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/6ff108ab664a/oncotarget-06-12558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/ac06ea8007f8/oncotarget-06-12558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/e228b9b5f826/oncotarget-06-12558-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e2/4494958/d19b9b6b127b/oncotarget-06-12558-g007.jpg

相似文献

1
Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression.肿瘤抑制性微小RNA-137负向调节Musashi-1及结直肠癌进展。
Oncotarget. 2015 May 20;6(14):12558-73. doi: 10.18632/oncotarget.3726.
2
Circ_KIAA1199 inhibits MSI1 degradation by targeting miR-34c-5p to drive the malignant cell behaviors and tumor growth of colorectal cancer.环状 RNA KIAA1199 通过靶向 miR-34c-5p 抑制 MSI1 降解,从而驱动结直肠癌细胞的恶性表型和肿瘤生长。
Anticancer Drugs. 2022 Jan 1;33(1):e134-e144. doi: 10.1097/CAD.0000000000001164.
3
Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.长链非编码RNA LEF1-AS1作为微小RNA-10a-5p的调节因子,通过激活AKT信号通路增强MSI1表达并促进肝癌细胞的化学抗性。
J Cell Biochem. 2021 Jan;122(1):86-99. doi: 10.1002/jcb.29833. Epub 2020 Aug 12.
4
Downregulation of Msi1 suppresses the growth of human colon cancer by targeting p21cip1.Msi1的下调通过靶向p21cip1抑制人结肠癌的生长。
Int J Oncol. 2015 Feb;46(2):732-40. doi: 10.3892/ijo.2014.2749. Epub 2014 Nov 13.
5
miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.miR-761通过靶向卵巢癌中的MSI1抑制肿瘤进展。
Tumour Biol. 2016 Apr;37(4):5437-43. doi: 10.1007/s13277-015-4377-z. Epub 2015 Nov 12.
6
Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b.MUSASHI1 在乳腺癌上皮细胞中的表达增加是由于 miR-125b 的下调。
BMC Mol Cell Biol. 2021 Feb 4;22(1):10. doi: 10.1186/s12860-021-00348-8.
7
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.致癌 RNA 结合蛋白 Musashi1 受肿瘤抑制 miRNA 的调控。
RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.
8
MicroRNA-544a Regulates Migration and Invasion in Colorectal Cancer Cells via Regulation of Homeobox A10.微小RNA-544a通过调控同源盒A10来调节结肠癌细胞的迁移和侵袭。
Dig Dis Sci. 2016 Sep;61(9):2535-44. doi: 10.1007/s10620-016-4186-2. Epub 2016 May 10.
9
Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.在宫颈癌中,Msi1通过靶向细胞周期检查点蛋白p21、p27和p53来促进肿瘤生长和细胞增殖。
Oncotarget. 2014 Nov 15;5(21):10870-85. doi: 10.18632/oncotarget.2539.
10
MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.微小RNA-361-5p通过靶向含葡萄球菌核酸酶结构域-1抑制结直肠癌和胃癌的生长与转移。
Oncotarget. 2015 Jul 10;6(19):17404-16. doi: 10.18632/oncotarget.3744.

引用本文的文献

1
regulates PTP61F, affecting insulin signaling, metabolic homeostasis, and starvation resistance in .调控 PTP61F,影响胰岛素信号、代谢稳态和饥饿抵抗。
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2319475121. doi: 10.1073/pnas.2319475121. Epub 2024 Jan 22.
2
Insights into Zika Virus Pathogenesis and Potential Therapeutic Strategies.寨卡病毒发病机制及潜在治疗策略的见解
Biomedicines. 2023 Dec 15;11(12):3316. doi: 10.3390/biomedicines11123316.
3
Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis.

本文引用的文献

1
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
2
Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.抗 CD44s 抗体抑制小鼠胰腺肿瘤的起始和放疗后复发。
Gastroenterology. 2014 Apr;146(4):1108-18. doi: 10.1053/j.gastro.2013.12.035. Epub 2014 Jan 5.
3
Musashi1 as a potential therapeutic target and diagnostic marker for lung cancer.Musashi1作为肺癌的潜在治疗靶点和诊断标志物。
结直肠癌细胞来源的外泌体 Circ_FMN2 通过 miR-338-3p/MSI1 轴促进肿瘤进展。
Appl Biochem Biotechnol. 2023 Dec;195(12):7322-7337. doi: 10.1007/s12010-023-04456-3. Epub 2023 Mar 30.
4
Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets.结直肠癌中上调的环状 RNA:治疗的新实体和治疗靶点鉴定的工具。
Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):132-153. doi: 10.21873/cgp.20369.
5
BCL2A1 and CCL18 Are Predictive Biomarkers of Cisplatin Chemotherapy and Immunotherapy in Colon Cancer Patients.BCL2A1和CCL18是结肠癌患者顺铂化疗和免疫治疗的预测生物标志物。
Front Cell Dev Biol. 2022 Feb 21;9:799278. doi: 10.3389/fcell.2021.799278. eCollection 2021.
6
Musashi-1-A Stemness RBP for Cancer Therapy?Musashi-1——一种用于癌症治疗的干性RNA结合蛋白?
Biology (Basel). 2021 May 5;10(5):407. doi: 10.3390/biology10050407.
7
Exosomal circ_IFT80 Enhances Tumorigenesis and Suppresses Radiosensitivity in Colorectal Cancer by Regulating miR-296-5p/MSI1 Axis.外泌体circ_IFT80通过调控miR-296-5p/MSI1轴增强结直肠癌的肿瘤发生并抑制放射敏感性。
Cancer Manag Res. 2021 Feb 24;13:1929-1941. doi: 10.2147/CMAR.S297123. eCollection 2021.
8
Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome.结直肠癌肿瘤干细胞的特征:分子生物标志物、信号通路和 miRNA 组学。
Int J Mol Sci. 2021 Feb 5;22(4):1603. doi: 10.3390/ijms22041603.
9
Upregulation of miR-137 Expression Suppresses Tumor Growth and Progression via Interacting with DNMT3a Through Inhibiting the PTEN/Akt Signaling in HCC.miR-137表达上调通过与DNMT3a相互作用抑制PTEN/Akt信号通路从而抑制肝癌的肿瘤生长和进展。
Onco Targets Ther. 2021 Jan 8;14:165-176. doi: 10.2147/OTT.S268570. eCollection 2021.
10
MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition.miR-137-3p 通过调控 KDM1A 依赖的上皮-间充质转化抑制结直肠癌细胞迁移。
Dig Dis Sci. 2021 Jul;66(7):2272-2282. doi: 10.1007/s10620-020-06518-6. Epub 2020 Aug 4.
Oncotarget. 2013 May;4(5):739-50. doi: 10.18632/oncotarget.1034.
4
The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells.新型 BH-3 模拟物苦玄参酮诱导人肝癌 [更正] 细胞中 Beclin-1 和 ROS 介导的自噬。
Cell Death Dis. 2013 Feb 7;4(2):e489. doi: 10.1038/cddis.2013.17.
5
Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.miR-137 抑制诱导的桩蛋白过表达促进结直肠癌的肿瘤进展和转移。
Carcinogenesis. 2013 Apr;34(4):803-11. doi: 10.1093/carcin/bgs400. Epub 2012 Dec 28.
6
MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.微小 RNA-137 是 HMGA1 的一个靶标,通过直接靶向 FMNL2 抑制 HMGA1 抑制结直肠癌细胞在小鼠体内的侵袭和转移。
Gastroenterology. 2013 Mar;144(3):624-635.e4. doi: 10.1053/j.gastro.2012.11.033. Epub 2012 Nov 27.
7
miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.miR-137 通过下调多个致癌靶基因抑制黑素瘤细胞的侵袭。
J Invest Dermatol. 2013 Mar;133(3):768-775. doi: 10.1038/jid.2012.357. Epub 2012 Nov 15.
8
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.ESMO 结肠癌和直肠癌患者管理共识指南。 个体化临床决策方法。
Ann Oncol. 2012 Oct;23(10):2479-2516. doi: 10.1093/annonc/mds236.
9
Defining the mode of tumour growth by clonal analysis.通过克隆分析定义肿瘤生长方式。
Nature. 2012 Aug 23;488(7412):527-30. doi: 10.1038/nature11344.
10
miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2.miR-137 在神经胶质瘤中经常下调,是 Cox-2 的负调控因子。
Eur J Cancer. 2012 Nov;48(16):3104-11. doi: 10.1016/j.ejca.2012.02.007. Epub 2012 Mar 7.